EMA Authorised: Lenalidomide Accord (lenalidomide) — Accord Healthcare S.L.U.

View source ↗

Summary

EMA has authorised Lenalidomide Accord for the treatment of multiple myeloma. The product is marketed by Accord Healthcare S.L.U.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide Accord (lenalidomide)

Snippet

Status: Authorised. Therapeutic area: Multiple Myeloma. MAH: Accord Healthcare S.L.U.. Decision date: 24/02/2026